FDA NDC Directory · JSON-LD · Markdown

ENBREL

NDC 58406-032 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic nameetanercept
Labeler / ManufacturerImmunex Corporation
Marketing categoryBiologic License Application · App BLA103795
Dosage form / routeSOLUTION · SUBCUTANEOUS
Active ingredientsETANERCEPT (50 mg/mL)
Marketing started20190607
Package count3

External sources

Source: openFDA. Public-domain (CC0).